Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Miromatrix Medical Inc. Common Stock (MIRO)

Biological Products, (no Disgnostic Substances)

https://www.miromatrix.com

Miromatrix Medical Inc is a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives. Its pipeline products include; MiroliverELAP is External Liver Assist Product and is designed to provide liver dialysis for acute liver failure patients, Mirokidney is fully implantable bioengineered kidney intended to treat patients with end-stage renal disease, Miroliver is fully implantable bioengineered liver intended to treat patients with acute and chronic liver failure, Miroheart, Mirolung, and Miropancreas.

6455 FLYING CLOUD DRIVE, SUITE 107
EDEN PRAIRIE, MN

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/24/2021

Market Cap

92,951,088

Shares Outstanding

27,420,000

Weighted SO

27,419,228

Total Employees

N/A

Upcoming Earnings

03/29/2024

Beta

0.0150

Last Div

0.0000

Range

0.906-4.35

Chg

0.0200

Avg Vol

163022

Mkt Cap

92951088

Exch

NASDAQ

Country

US

Phone

952 942 6000

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

97.0233

EV Multiple

-3.3621

P/FV

5.9575

Div Yield %

0.0000

P/E

-3.4142

PEG

0.2959

Payout

-0.0163

Current Ratio

3.4621

Quick Ratio

3.2526

Cash Ratio

1.2316

DSO

34.5212

DIO

584.0730

Op Cycle

618.5942

DPO

765.3057

CCC

-146.7115

Gross Margin

0.4781

Op Margin

-29.7318

Pretax Margin

-28.6111

Net Margin

-28.3087

Eff Tax Rate

-0.0027

ROA

-1.1580

ROE

-1.1921

ROCE

-1.5434

NI/EBT

0.9894

EBT/EBIT

0.9623

EBIT/Rev

-29.7318

Debt Ratio

0.1376

D/E

0.2074

LT Debt/Cap

0.1523

Total Debt/Cap

0.1718

Int Coverage

-613.6916

CF/Debt

-7.5429

Equity Multi

1.5069

Rec Turnover

10.5732

Pay Turnover

0.4769

Inv Turnover

0.6249

FA Turnover

0.1538

Asset Turnover

0.0409

OCF/Share

-0.8901

FCF/Share

-0.8988

Cash/Share

0.5880

OCF/Sales

-25.3758

FCF/OCF

1.0099

CF Coverage

-7.5429

ST Coverage

-56.4145

CapEx Coverage

-101.4513

Div&CapEx Cov

-35.6997

P/BV

5.9575

P/B

5.9575

P/S

97.0233

P/E

-3.4142

P/FCF

-3.7861

P/OCF

-3.8088

P/CF

-3.8088

PEG

0.2959

P/S

97.0233

EV Multiple

-3.3621

P/FV

5.9575

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation